세계의 ISH(In Situ Hybridization) 시장 : 산업 규모, 점유율, 동향, 기회, 예측, 제품 유형별, 기술별, 용도별, 최종 사용자별, 지역별, 경쟁별(2020-2030년)
In Situ Hybridization Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Technology, By Application, By End User, By Region and Competition, 2020-2030F
상품코드:1728077
리서치사:TechSci Research
발행일:2025년 05월
페이지 정보:영문 182 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 ISH(In Situ Hybridization) 시장은 2024년에 18억 8,000만 달러로 평가되었고, 2030년에는 29억 1,000만 달러에 이를 것으로 예측되며, 예측 기간 동안 CAGR 7.54%로 성장할 전망입니다.
ISH는 조직 샘플 내 특정 핵산 서열을 정확히 검출할 수 있는 능력으로 인해 분자 진단 및 생물의학 연구 분야에서 필수적인 도구로 점점 더 인정받고 있습니다. 질병의 정확한 조기 진단에 대한 수요, 특히 종양학과 유전적 질환 분야에서 증가하고 있습니다. ISH는 유전자 발현 패턴과 변이를 상세히 시각화할 수 있어 맞춤형 의료 전략의 핵심 요소로 자리매김하고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모(2024년)
18억 8,000만 달러
시장 규모(2030년)
29억 1,000만 달러
CAGR(2025-2030년)
7.54%
급성장 부문
세포 유전학
최대 시장
북미
자동화 염색 플랫폼과 고해상도 이미징과 같은 기술 혁신은 ISH의 사용 편의성과 신뢰성을 향상시켜 임상 실험실 및 연구 기관에서의 광범위한 채택을 촉진하고 있습니다. 다중 검출 기술과 개선된 프로브 설계는 여러 유전적 표적을 동시에 검출할 수 있도록 하여 진단 효율성과 환자 예후를 개선하고 있습니다. 정밀 의학이 계속 발전함에 따라 ISH는 맞춤형 치료 옵션 제공에서의 중요성이 확대되며, 현대 진단 및 신약 개발에서의 역할을 강화하고 있습니다
최종 사용자별(병원 및 진단연구소, 학술연구기관, 제약 및 생명 공학 기업, 계약 연구 기관, 기타)
기업별(2024년)
지역별
시장 맵
제6장 북미의 ISH(In Situ Hybridization) 시장 전망
시장 규모와 예측
시장 점유율 및 예측
북미 : 국가별 분석
미국
멕시코
캐나다
제7장 유럽의 ISH(In Situ Hybridization) 시장 전망
시장 규모와 예측
시장 점유율 및 예측
유럽 : 국가별 분석
프랑스
독일
영국
이탈리아
스페인
제8장 아시아태평양의 ISH(In Situ Hybridization) 시장 전망
시장 규모와 예측
시장 점유율 및 예측
아시아태평양 : 국가별 분석
중국
인도
한국
일본
호주
제9장 남미의 ISH(In Situ Hybridization) 시장 전망
시장 규모와 예측
시장 점유율 및 예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 ISH(In Situ Hybridization) 시장 전망
시장 규모와 예측
시장 점유율 및 예측
중동 및 아프리카 : 국가별 분석
남아프리카
사우디아라비아
아랍에미리트(UAE)
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
합병과 인수
제품 출시
최근 동향
제13장 Porter's Five Forces 분석
업계 내 경쟁
신규 진입의 가능성
공급자의 힘
고객의 힘
대체품의 위협
제14장 경쟁 구도
Thermo Fisher Scientific, Inc.
Abbott Laboratories Inc.
PerkinElmer, Inc.
Bio View Ltd.
Agilent Technologies, Inc.
Merck KGaA
Bio:Rad Laboratories, Inc.
Biotechne Corporation
F. Hoffmann Roche AG
Biocare Medical LLC
제15장 전략적 제안
제16장 기업 소개와 면책사항
HBR
영문 목차
영문목차
The Global In Situ Hybridization (ISH) Market was valued at USD 1.88 Billion in 2024 and is projected to reach USD 2.91 Billion by 2030, growing at a CAGR of 7.54% during the forecast period. ISH is increasingly recognized as a vital tool in molecular diagnostics and biomedical research due to its capability to precisely detect specific nucleic acid sequences within tissue samples. The demand for accurate and early detection of diseases, particularly in oncology and genetic disorders, is driving market growth. ISH enables detailed visualization of gene expression patterns and mutations, making it a cornerstone in personalized medicine strategies.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 1.88 Billion
Market Size 2030
USD 2.91 Billion
CAGR 2025-2030
7.54%
Fastest Growing Segment
Cytogenetics
Largest Market
North America
Technological innovations such as automated staining platforms and high-resolution imaging are enhancing the usability and reliability of ISH, facilitating broader adoption in clinical laboratories and research institutions. Developments in multiplex assays and improved probe designs are enabling simultaneous detection of multiple genetic targets, improving diagnostic efficiency and patient outcomes. As precision medicine continues to advance, ISH's relevance in delivering targeted treatment options is expanding, strengthening its role in modern diagnostics and drug development.
Key Market Drivers
Rising Incidence of Cancer and Genetic Disorders
The increasing global burden of cancer and genetic diseases is a primary growth driver for the In Situ Hybridization market. According to the World Health Organization, cancer accounted for approximately 20 million new cases and 9.7 million deaths in 2022. Lung, breast, and colorectal cancers were among the most prevalent. These rising figures underscore the need for accurate molecular diagnostic tools that can provide specific and early detection. ISH, particularly Fluorescent In Situ Hybridization (FISH), plays a critical role in identifying genetic abnormalities, gene fusions, and chromosomal rearrangements within tissue samples, aiding in diagnosis, prognosis, and treatment planning.
Key Market Challenges
High Cost of ISH Technology and Reagents
The adoption of ISH techniques faces a significant hurdle due to the high costs associated with equipment and consumables. Advanced instruments such as hybridization systems and imaging platforms require substantial investment, which can be restrictive for smaller laboratories and facilities in developing regions. Additionally, reagents including specialized probes and buffers contribute to the overall expense, making frequent use of ISH less feasible in cost-sensitive healthcare environments. These cost barriers may limit the accessibility of high-precision diagnostics, particularly where budget constraints impact healthcare delivery.
Key Market Trends
Integration with Personalized Medicine
A notable trend shaping the ISH market is its growing integration into personalized medicine. ISH techniques, especially FISH, are being leveraged to detect genetic mutations and biomarkers that inform individualized treatment regimens. This alignment with precision healthcare is particularly prominent in oncology, where ISH supports targeted therapies by identifying specific molecular features of tumors. Companion diagnostics utilizing ISH allow clinicians to tailor treatments based on a patient's genetic profile, enhancing therapeutic efficacy and minimizing adverse effects. This synergy with precision medicine is reinforcing the value of ISH as a diagnostic standard in both clinical and research settings.
Key Market Players
Thermo Fisher Scientific, Inc.
Abbott Laboratories Inc.
PerkinElmer, Inc.
Bio View Ltd.
Agilent Technologies, Inc.
Merck KGaA
Bio-Rad Laboratories, Inc.
Biotechne Corporation
F. Hoffmann Roche AG
Biocare Medical LLC
Report Scope:
In this report, the Global In Situ Hybridization Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
In Situ Hybridization Market, By Product:
Instruments
Consumables & Accessories
Software
Services
In Situ Hybridization Market, By Technology:
Fluorescent In Situ Hybridization
Chromogenic In Situ Hybridization
In Situ Hybridization Market, By Application:
Cancer
Cytogenetics
Infectious Diseases
Neuroscience
Immunology
Others
In Situ Hybridization Market, By End User:
Hospitals & Diagnostic Laboratories
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Others
In Situ Hybridization Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global In Situ Hybridization Market.
Available Customizations:
Global In Situ Hybridization Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customer
5. Global In Situ Hybridization Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Instruments, Consumables & Accessories, Software, Services)
5.2.2. By Technology (Fluorescent In Situ Hybridization, Chromogenic In Situ Hybridization)
5.2.3. By Application (Cancer, Cytogenetics, Infectious Diseases, Neuroscience, Immunology, Others)
5.2.4. By End User (Hospitals & Diagnostic Laboratories, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Others)
5.2.5. By Company (2024)
5.2.6. By Region
5.3. Market Map
6. North America In Situ Hybridization Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Technology
6.2.3. By Application
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States In Situ Hybridization Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Technology
6.3.1.2.3. By Application
6.3.1.2.4. By End User
6.3.2. Mexico In Situ Hybridization Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Technology
6.3.2.2.3. By Application
6.3.2.2.4. By End User
6.3.3. Canada In Situ Hybridization Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Technology
6.3.3.2.3. By Application
6.3.3.2.4. By End User
7. Europe In Situ Hybridization Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Technology
7.2.3. By Application
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. France In Situ Hybridization Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Technology
7.3.1.2.3. By Application
7.3.1.2.4. By End User
7.3.2. Germany In Situ Hybridization Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Technology
7.3.2.2.3. By Application
7.3.2.2.4. By End User
7.3.3. United Kingdom In Situ Hybridization Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Technology
7.3.3.2.3. By Application
7.3.3.2.4. By End User
7.3.4. Italy In Situ Hybridization Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Technology
7.3.4.2.3. By Application
7.3.4.2.4. By End User
7.3.5. Spain In Situ Hybridization Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Technology
7.3.5.2.3. By Application
7.3.5.2.4. By End User
8. Asia-Pacific In Situ Hybridization Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Technology
8.2.3. By Application
8.2.4. By End User
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China In Situ Hybridization Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Technology
8.3.1.2.3. By Application
8.3.1.2.4. By End User
8.3.2. India In Situ Hybridization Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Technology
8.3.2.2.3. By Application
8.3.2.2.4. By End User
8.3.3. South Korea In Situ Hybridization Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Technology
8.3.3.2.3. By Application
8.3.3.2.4. By End User
8.3.4. Japan In Situ Hybridization Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Technology
8.3.4.2.3. By Application
8.3.4.2.4. By End User
8.3.5. Australia In Situ Hybridization Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Technology
8.3.5.2.3. By Application
8.3.5.2.4. By End User
9. South America In Situ Hybridization Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Technology
9.2.3. By Application
9.2.4. By End User
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil In Situ Hybridization Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Technology
9.3.1.2.3. By Application
9.3.1.2.4. By End User
9.3.2. Argentina In Situ Hybridization Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Technology
9.3.2.2.3. By Application
9.3.2.2.4. By End User
9.3.3. Colombia In Situ Hybridization Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Technology
9.3.3.2.3. By Application
9.3.3.2.4. By End User
10. Middle East and Africa In Situ Hybridization Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Technology
10.2.3. By Application
10.2.4. By End User
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa In Situ Hybridization Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Technology
10.3.1.2.3. By Application
10.3.1.2.4. By End User
10.3.2. Saudi Arabia In Situ Hybridization Market Outlook
